300 related articles for article (PubMed ID: 3291253)
21. Long-term results of cyclosporine monotherapy in kidney transplantation.
Griffin PJ; Salaman JR
Transplant Proc; 1991 Feb; 23(1 Pt 2):992-3. PubMed ID: 1989356
[No Abstract] [Full Text] [Related]
22. Clinical and socioeconomic benefits of serological HLA-DR matching for renal transplantation over three eras of immunosuppression regimens at a single unit.
Taylor CJ; Welsh KI; Gray CM; Bunce M; Bayne AM; Sutton PM; Gray DW; Ting A; Morris PJ
Clin Transpl; 1993; ():233-41. PubMed ID: 7918156
[TBL] [Abstract][Full Text] [Related]
23. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team.
Martin S; Connolly J; Jos V
Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295
[No Abstract] [Full Text] [Related]
24. Blood transfusions and HLA compatibility in first cadaveric kidney transplants treated with cyclosporine A.
Garcia LF; Arango AM; Henao JE; Arbelaez M
Transplant Proc; 1988 Aug; 20(4):715-9. PubMed ID: 3043844
[TBL] [Abstract][Full Text] [Related]
25. Beneficial effects of some donor-recipient HLA-DR mismatches on cadaveric graft survival: proposal for a new selection policy of recipients.
Vereerstraeten P; Andrien M; De Pauw L; Dupont E; Goldman M; Abramowicz D; Kinnaert P
Transplant Proc; 1991 Feb; 23(1 Pt 1):385-6. PubMed ID: 1990560
[No Abstract] [Full Text] [Related]
26. Effects of HLA matching in cadaver renal transplants.
Najarian JS; Migliori RJ; Simmons RL; Ascher NL; Payne WD; Dunn D; Sutherland DE; Fryd DS
Transplant Proc; 1988 Jun; 20(3 Suppl 3):249-56. PubMed ID: 3291251
[No Abstract] [Full Text] [Related]
27. Blood transfusion experience for cyclosporine/prednisone-treated renal allograft recipients at the University of Texas Medical School at Houston.
Kerman RH; Van Buren CT; Lewis RM; Kahan BD
Clin Transpl; 1988; ():167-70. PubMed ID: 3154469
[TBL] [Abstract][Full Text] [Related]
28. Beneficial influence of matching for D/DR antigens and treatment with cyclosporin-A on kidney graft survival in transfused rhesus monkeys.
Borleffs JC; Marquet RL; Neuhaus P
Proc Eur Dial Transplant Assoc; 1981; 18():446-53. PubMed ID: 6460246
[TBL] [Abstract][Full Text] [Related]
29. HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation--a changing picture with cyclosporin.
Lundgren G; Groth CG; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Husberg B; Klintmalm G; Maurer W
Lancet; 1986 Jul; 2(8498):66-9. PubMed ID: 2873380
[TBL] [Abstract][Full Text] [Related]
30. Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy.
Knight RJ; Kerman RH; Welsh M; Golden D; Schoenberg L; Van Buren CT; Lewis RM; Kahan BD
Transplantation; 1991 Feb; 51(2):355-9. PubMed ID: 1994527
[TBL] [Abstract][Full Text] [Related]
31. Predictors of outcome in cyclosporine-treated recipients of second renal transplants.
Merion RM; Campbell DA; Dafoe DC; Rosenberg L; Rocher LL; Turcotte JG
Transplant Proc; 1988 Jun; 20(3 Suppl 3):194-7. PubMed ID: 3291240
[No Abstract] [Full Text] [Related]
32. The effect of triple therapy on graft outcome in renal transplantation.
Cağlar S; Taşdemir I; Turgan C; Yasavul U; Bakkaloğlu M; Erkan I
Transplant Proc; 1988 Jun; 20(3 Suppl 3):140-2. PubMed ID: 3291228
[No Abstract] [Full Text] [Related]
33. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
[No Abstract] [Full Text] [Related]
34. Comparison of antithymocyte globulin antirejection treatment in renal transplant patients with either cyclosporine or azathioprine as basic immunosuppression.
Hoitsma AJ; Wetzels JF; Berden JH; Koene RA
Transplant Proc; 1987 Oct; 19(5):3589-91. PubMed ID: 3313864
[No Abstract] [Full Text] [Related]
35. Effect of DR and DR6 matching on cadaver kidney transplant survival.
Reyman TA; Toledo-Pereyra LH
Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848
[No Abstract] [Full Text] [Related]
36. Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine.
Ford HR; Fryd DS; Canafax DM; Ascher NL; Dunn D; Sutherland DE; Najarian JS; Simmons RL
Transplant Proc; 1988 Jun; 20(3 Suppl 3):8-12. PubMed ID: 3291316
[No Abstract] [Full Text] [Related]
37. The current role of pre-transplant blood transfusions and tissue typing in cadaveric renal transplantation.
Koyle MA; Rajfer J; Mickey MR; Glassock RJ; Ward HJ
J Urol; 1987 Nov; 138(5):1141-3. PubMed ID: 3312638
[TBL] [Abstract][Full Text] [Related]
38. Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation.
Arbelaez M; Mejia G; Henao JE; Garcia A; Arango JL; Velasquez A; Restrepo J; Garcia LF
Transplant Proc; 1992 Dec; 24(6):3096-7. PubMed ID: 1466072
[No Abstract] [Full Text] [Related]
39. HLA class II induction and cellular infiltration are effectively suppressed by triple therapy in renal allografts.
McWhinnie DL; Fuggle SV; Azevedo LS; Jones RM; Morris PJ
Transplant Proc; 1987 Oct; 19(5):3628-9. PubMed ID: 3313873
[No Abstract] [Full Text] [Related]
40. The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation.
First MR; Alexander JW; Wadhwa N; Penn I; Munda R; Fidler JP; Weiskittel P
Transplant Proc; 1986 Apr; 18(2 Suppl 1):132-5. PubMed ID: 3515680
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
